BioKangtai | Sustainability Performance
Develops and manufactures biological products and vaccines. Operations include research, production, and distribution of pharmaceuticals for immunization, diagnostics, and treatment purposes, with compliance to regulatory standards and quality assurance processes.
1992
China
1,001 - 5,000 employees
Biotechnology
$100M - 500M in revenue
$1M - 10M in profitability
Sustainability Ranking & Industry Benchmark
#11016
Overall#754
in China#231
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
P/E ratio
Revenue & EBITDA
$2.7BFY2024 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
15.7%FY2024
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
2.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
3.2
▼ 20.1%
3.5
▼ 9.5%
2.7
▼ 10.1%
4.0
2027Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Available
Recycling policy
Not available
Workplace health & safety policy
Available
23%
Independent Directors
3 out of 13 incl. management
Overall score
59
Environment
59
Social
78
Governance
39
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
